Search results - 12 results

Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method

multiplied with the result of the CRC. Results: Approximately 43.4% (95% CI 28.9% – 58.0%) of the PWID tested positive for HCV antibodies in Brussels. This corresponds to 304 (95% CI 160 – 547) PWID in ...

Hepatitis C virus prevalence in Belgium

Publication Type: Peer reviewed scientific article Authors: L Van Baelen; Johan Van der Heyden Source: Experimental Results, Volume 2 (2021) Keywords: Belgium cross-sectional study Hepatitis ...

Hepatitis C virus prevalence in Belgium

Publication Type: Peer reviewed scientific article Authors: L Van Baelen; Johan Van der Heyden Source: Experimental Results, Volume 2 (2021) Keywords: Belgium cross-sectional study Hepatitis ...

Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.

Lynen; Steven Van Gucht; Benoît Kabamba Mukadi Source: Infect Dis Ther, Volume 9, Issue 3 (2020) Keywords: Genotype Hepatitis C Abstract: INTRODUCTION: We aim to report on results and challenges of ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

ELISA and confirmed with a line-immunoassay (LIA). In specimens with undetermined or positive LIA result, HCV viral load was measured. Specimens were classified seronegative, seropositive with resolved ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

RESULTS: For the study period, 11,033 unique records collected by the participating laboratories were used for further investigation. HCV genotype 1 was the most prevalent (53.6%) genotype in Belgium, with ...

Hepatitis E virus serology and PCR: does the methodology matter?

and from 15.7% to 20.0% for IgG. All but two of the results of the PCR assays performed on clinical samples agreed. However, 10 out of 16 EQC samples results showed major discrepancies. We observed ...

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

envelope protein 1 (E1) are not fully identified. Here we describe the detailed characterization of a human mAb, designated A6, generated from an HCV genotype 1b infected patient. ELISA results showed ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

analysis is the result of a descriptive crosssectional study, based on data extracted from the linkage between a database of people in treatment for substance use disorders in Belgium and a database of the ...

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method

on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID. Methods We ...

QR code

QR code for this page URL